准确预测蛋白质-配体结合亲和力在药物发现中至关重要，尤其是在命中化合物到先导化合物以及先导化合物优化阶段，然而配体力场的局限性仍然影响了预测准确性。在这项工作中，我们验证了利用神经网络势能（NNPs）进行相对结合自由能（RBFE）计算的准确性。我们采用了一种基于TensorNet架构的小分子新型NNP模型AceFF 1.0，该模型能够适用于多样化的药物样化合物，包括所有重要的化学元素并支持带电分子。通过已建立的基准测试，我们显示相比于分子力学中的GAFF2和NNPs中的ANI2-x，结合亲和力预测的整体准确性和相关性有所提高。与OPLS4相比，虽然准确性略低，但相关性相当。此外，我们还表明可以使用2 fs的时间步长运行NNP模拟，至少比之前的NNP模型大两倍，提供了显著的速度提升。结果表明，基于NNPs的自由能计算方法具有进一步发展的潜力，并且当前一代已经显示出其实际应用价值。代码和NNP模型可供研究使用。

Accurate prediction of protein-ligand binding affinities is crucial in drug discovery, particularly during hit-to-lead and lead optimization phases, however, limitations in ligand force fields continue to impact prediction accuracy. In this work, we validate relative binding free energy (RBFE) accuracy using neural network potentials (NNPs) for the ligands. We utilize a novel NNP model, AceFF 1.0, based on the TensorNet architecture for small molecules that broadens the applicability to diverse drug-like compounds, including all important chemical elements and supporting charged molecules. Using established benchmarks, we show overall improved accuracy and correlation in binding affinity predictions compared with GAFF2 for molecular mechanics and ANI2-x for NNPs. Slightly less accuracy but comparable correlations with OPLS4. We also show that we can run the NNP simulations at 2 fs timestep, at least two times larger than previous NNP models, providing significant speed gains. The results show promise for further evolutions of free energy calculations using NNPs while demonstrating its practical use already with the current generation. The code and NNP model are publicly available for research use.